Abstract
Ciprofloxacin is a broad spectrum fluoroquinolone antibacterial agent. In order to investigate the effect of cyclosporin A on the pharmacokinetics of ciprofloxacin in rats, a technique using blood microdialysis coupled to liquid chromatography was employed in this study. Microdialysis probe was inserted into the jugular vein/right atrium of male Sprague–Dawley rat for sampling of a protein unbound drug. The pharmacokinetics between i.v. doses of 20 or 50 mg/kg ciprofloxacin were compared with those treated with a single i.v. dose of 20 mg/kg cyclosporin A prior to the ciprofloxacin administrations. This study showed that a single dose treatment with cyclosporin A resulted in a significant increase in the pharmacokinetic parameters estimated for the higher dose of ciprofloxacin (50 mg/kg) but no significant difference at the lower dose of ciprofloxacin (20 mg/kg). The results suggest that cyclosporin A alters the pharmacokinetics of ciprofloxacin in rats. Possible mechanisms for this interaction include the blocking by cyclosporin A of the protein binding of ciprofloxacin with P-glycoprotein in rat blood.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
